Key result
Home blood pressure monitoring improves blood pressure control, diagnoses white-coat hypertension, and predicts cardiovascular risk compared with office-based monitoring.
Why the study?
Does home blood pressure monitoring improve BP control and cardiovascular risk prediction compared to office-based monitoring in patients with hypertension?
Does home blood pressure monitoring improve BP control and cardiovascular risk prediction compared to office-based monitoring in patients with hypertension?
Answers are grounded in this paper and cite their sources.
Home blood pressure monitoring is a recommended, cost-effective tool that improves BP control and risk prediction compared to office-based monitoring, with new cuff technologies improving reading accuracy.
Hypertension is the most common preventable cause of cardiovascular disease. Home blood pressure monitoring (HBPM) is a self-monitoring tool that can be incorporated into the care for patients with hypertension and is recommended by major guidelines. A growing body of evidence supports the benefits of patient HBPM compared with office-based monitoring: these include improved control of BP, diagnosis of white-coat hypertension and prediction of cardiovascular risk. Furthermore, HBPM is cheaper and easier to perform than 24-hour ambulatory BP monitoring (ABPM). All HBPM devices require validation, however, as inaccurate readings have been found in a high proportion of monitors. New technology features a longer inflatable area within the cuff that wraps all the way round the arm, increasing the 'acceptable range' of placement and thus reducing the impact of cuff placement on reading accuracy, thereby overcoming the limitations of current devices.
No takes yet. Share an insight, caveat, or question.
Thomas M. MacDonald (2015) conducted a review in Hypertension. Home blood pressure monitoring (HBPM) vs. Office-based monitoring and 24-hour ambulatory BP monitoring (ABPM) was evaluated. Home blood pressure monitoring improves blood pressure control, diagnoses white-coat hypertension, and predicts cardiovascular risk compared with office-based monitoring.
Synapse has enriched 10 related papers. Consider them for comparative context: